article thumbnail

Help Turn Occasional Shoppers into Loyal Customers by Investing in the Front End

Drug Topics

Private-Label Partnerships can Streamline Operations and Enhance the Customer Experience Offering a broad selection of private-label OTC products can help your pharmacy stay competitive and support your customers’ evolving needs. Private-label brands allow you to deliver the same quality as larger name brands, often at a lower cost.

article thumbnail

Hair Loss Therapy Shows Potential for Regeneration in Phase 2 Trial

Drug Topics

After the randomized portion of the study, patients were eligible to enroll in an open-label extension study for 3 months to assess the long term safety of PP405. Patients applied the therapy or placebo once per day for 4 weeks and were followed for up to 12 weeks.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Healthy Diet Provides Health Benefits, Even Without Weight Loss

Drug Topics

Image Credit: sonyakamoz - stock.adobe.com "We have been conditioned to equate weight loss with health, and weight loss-resistant individuals are often labeled as failures,” Anat Yaskolka Meir, PhD, postdoctoral research fellow in the department of epidemiology at Harvard Chan School, said in a news release.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

of YA with obesity were prescribed OMs—predominantly GLP-1s approved for adults but used off label for younger people. Despite the high prevalence of obesity among children and YA, OM utilization remains low,” wrote authors of the abstract. 1 In the final year of the analysis (2024), just 1.5% of adolescents and 5.7%

article thumbnail

Merck’s Keytruda wins coveted FDA nod around surgery for early lung cancer—with a surprise

Fierce Pharma

Up until this point, immune checkpoint inhibitors have been allowed to treat early-stage non-small cell lung cancer (NSCLC) either before or after surgery. The drug's label already includes an overall survival win from a key trial.

FDA 141
article thumbnail

FDA declines Eli Lilly’s bowel disease drug over manufacturing issues

Pharmafile

However, concerns weren’t expressed over the clinical data package, safety or label for the medicine. Mirikizumab was hoped to become a new drug treatment for ulcerative colitis (UC), a condition where abnormal reactions in the immune system cause inflammation in the inner lining of the colon. read more

FDA 119
article thumbnail

EU gives narrower label to Apellis, Sobi’s PNH drug

pharmaphorum

Apellis Pharma and partner Sobi have won EU approval for their paroxysmal nocturnal haemoglobinuria (PNH) drug pegcetacoplan in Europe, with a more restricted label than in the US. The post EU gives narrower label to Apellis, Sobi’s PNH drug appeared first on.